Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Antonina Barreca"'
Publikováno v:
International Journal of Business and Applied Social Science. :34-51
The current uncertain, dynamic scenario calls for a systemic perspective when referring to organizational complexity and behavior. Our research contributes to the analysis of organizational complexity through multidimensional behavioral mapping. Our
Autor:
Massimo Giusti, Diego Ferone, Marilena Sidoti, Antonina Barreca, Eugenia Resmini, Francesco Minuto
Publikováno v:
Clinical Endocrinology. 63:294-297
Summary Objectives Three major therapeutic modalities (transsphenoidal surgery, radiotherapy and medical therapy) are currently available for acromegaly. Although surgery is regarded as the primary option, 50–60% of macroadenomas require further tr
Publikováno v:
Journal of Endocrinological Investigation. 26:919-923
Besides anabolic steroids, the most common performance-enhancing hormones are erythropoietin (EPO), insulin, GH, and gonadotropins, mostly indistinguishable from endogenous hormones and with very short half-life. This makes virtually impossible to de
Autor:
Simona Garrone, Giorgio Radetti, Marilena Sidoti, Francesco Minuto, Mauro Bozzola, Antonina Barreca
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 87:5455-5460
The height of subjects with constitutionally tall stature (CTS) is at least 2 sd above the mean of subjects of the same age and sex. Apart from a few discordant data on the role of GH and its direct mediator, IGF-I, no studies have been conducted on
Autor:
Marina Vivarelli, Simona Garrone, Elena Fattori, Fabrizio De Benedetti, Alberto Martini, Mara Oliveri, Tonino Alonzi, Cristina Meazza, Patrizia Pignatti, Antonina Barreca
Publikováno v:
Endocrinology. 142:4818-4826
Stunted growth is a common complication of childhood diseases characterized by chronic inflammation or infections. We previously demonstrated that NSE/hIL-6 transgenic mice, overexpressing the inflammatory cytokine IL-6 since early phase of life, sho
Autor:
Antonina Barreca, A. Rollero, G. Murialdo, Francesco Copello, Alessandro Polleri, Flavio Nobili, G. Timossi, Guido Rodriguez, M. V. Gianelli
Publikováno v:
Journal of Endocrinological Investigation. 24:139-146
Changes in the hypothalamus-pituitary- adrenal axis (HPAA) function, entailing elevated cortisol circulating titres, occur in aging and in some neurological conditions, such as Alzheimer’s disease (AD). Excess cortisol has neurotoxic effects which
Autor:
Francesco Minuto, Antonina Barreca, Maura Arosio, Giovanni Faglia, Simona Garrone, Paolo Bruzzi
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 86:1091-1098
In normal subjects the main form of circulating insulin-like growth factor (IGF) is the 150-kDa complex. This complex is formed by the IGF peptide, the acid-stable IGF-binding protein-3 (IGFBP-3), and the acid-labile subunit (ALS). Experimental and c
Autor:
Chris Robertson, Maura Mezzetti, Andrea Decensi, Rosalba Torrisi, Antonina Barreca, Harriet Johansson, Francesca Pigatto
Publikováno v:
International Journal of Cancer. 87:601-605
The insulin-like growth factor (IGF) system is widely involved in human carcinogenesis. A significant association between high circulating IGF-I concentrations and an increased risk of lung, colon, prostate and pre-menopausal breast cancer has recent
Publikováno v:
Metabolism. 47:1490-1493
In obese children, both spontaneous and stimulated growth hormone (GH) secretion are impaired but a normal or increased height velocity is usually observed. This study was undertaken to explain the discrepancy between impaired GH secretion and normal
Autor:
Aliana Guerrieri-Gonzaga, Alberto Costa, Peter Boyle, Andrea Decensi, Antonina Barreca, Sara Gandini, Chris Robertson, Federica Salinaro, Roberto Travaglini, Harriet Johansson, G. Farante, Maria Teresa Sandri, Umberto Veronesi, Antonella Tessadrelli, D. Bettega, Bernardo Bonanni
Publikováno v:
Scopus-Elsevier
Background: Results of a clinical trial recently completed in the United States indicate that administration of tamoxifen (20 mg/day) to women at risk can reduce breast cancer incidence by approximately 50% but is associated with an increased risk of